MiniMed adds Alcon CEO David Endicott to board

AltC Acquisition Corp. (formerly Churchill Capital Corp. VIII)
MiniMed Group, Inc.
Medtronic Plc

AltC Acquisition Corp. (formerly Churchill Capital Corp. VIII)

ALCC

0.00

MiniMed Group, Inc.

MMED

0.00

Medtronic Plc

MDT

0.00
  • MiniMed named Alcon CEO David Endicott and Medtronic executive Linnea Burman to its board, expanding directors to 11.
  • Endicott joined the Compensation and Talent Committee; he has led Alcon since 2018 and previously ran Hospira Infusion Systems at Pfizer.
  • Burman was designated by majority shareholder Medtronic; she is SVP and president of Neurovascular with 19 years in senior operating roles.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MiniMed Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA93805) on June 29, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.